Workflow
Monster Beverage to Report Financial Results for 2025 Fourth Quarter on February 26, 2026
Globenewswire· 2026-02-19 17:30
Core Viewpoint - Monster Beverage Corporation will report its fourth quarter results for the period ending December 31, 2025, on February 26, 2026, after market close, with a conference call hosted by CEO Hilton Schlosberg to discuss the financial results and operations [1]. Company Overview - Monster Beverage Corporation is based in Corona, California, and operates primarily through its consolidated subsidiaries, which develop and market a wide range of energy drinks and other beverages [3]. - The company's energy drink portfolio includes brands such as Monster Energy®, Monster Energy Ultra®, Juice Monster®, Java Monster®, and many others, totaling a diverse selection of products [3]. - In addition to energy drinks, the company also develops and markets craft beers, flavored malt beverages, and hard seltzers under various brands [3]. Investor Communication - The investor conference call will be accessible to all interested parties via a live audio webcast on the company's website, with an archived version available for approximately one year for those unable to attend live [2].
Invitation to Tallinna Sadam Investor Conference Webinar for the unaudited results of Q4 2025
Globenewswire· 2026-02-19 17:30
Core Viewpoint - Tallinna Sadam is hosting an investor conference webinar to present its unaudited results for Q4 and the full year of 2025, scheduled for February 26, 2026 [1] Group 1: Webinar Details - The webinar will be conducted on the Microsoft Teams platform in two languages: Estonian at 10:00 EET and English at 11:00 EET [1] - The Chairman of the Management Board, Valdo Kalm, and the Head of Investor Relations, Angelika Annus, will present the results and address questions from participants [1] - Participants are encouraged to submit questions in advance due to time limitations [1] Group 2: Company Overview - Tallinna Sadam is one of the largest cargo and passenger port complexes in the Baltic Sea region, providing both passenger and freight services [3] - The company operates in the shipping business through subsidiaries, including OÜ TS Laevad, which offers ferry services, and OÜ TS Shipping, which charters the multifunctional vessel Botnica for icebreaking and offshore services [3] - Tallinna Sadam is also a shareholder in AS Green Marine, which provides waste management services [3]
INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB
Globenewswire· 2026-02-19 17:15
Core Insights - INmune Bio Inc. is hosting a webinar on February 26, 2026, to discuss CORDStrom for treating recessive dystrophic epidermolysis bullosa (RDEB) and present new data from the MissionEB clinical study [1][2] Group 1: CORDStrom Overview - CORDStrom™ is a patent-pending cell medicine made from aseptic, allogeneic, pooled human umbilical cord-derived mesenchymal stromal cells (hucMSCs) designed for injection or infusion [4] - The platform utilizes proprietary techniques for screening, pooling, and expanding hucMSCs, allowing for the creation of off-the-shelf medicines for complex inflammatory and autoimmune diseases [4] - CORDStrom™ products aim to provide consistent, scalable, and affordable cellular medicines with optimized characteristics for various indications [4] Group 2: Clinical Trial Insights - The upcoming webinar will highlight the systemic disease-modifying capabilities of CORDStrom™ in RDEB patients, contrasting it with current standard-of-care options that focus on topical treatments [2] - Key clinical benchmarks to be discussed include improvements in the EBDASI (EB Disease Activity and Scarring Index), nutritional and weight gain data in pediatric patients, reductions in pain and itch, and enhancements in quality of life [6] - Principal investigators, including Dr. Anna Martinez and Prof. Mark Lowdell, will provide insights from the MissionEB study, emphasizing the systemic nature of RDEB and the scientific rationale for using CORDStrom™ [6][3] Group 3: Company Background - INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments targeting the innate immune system, with three product platforms: CORDStrom™, XPro™, and INKmune® [7] - The company is publicly traded on NASDAQ under the ticker INMB and is dedicated to advancing therapies for various diseases [7]
RUBIS: Change to the financial calendar
Globenewswire· 2026-02-19 17:00
Paris, 19 February 2026, 6:00pm The 2025 full-year results will be released on Thursday 12 March 2026 before market opening (instead of Thursday 12 March 2026 after market close). The audio webcast for analysts and investors will be held on Thursday 12 March 2026 at 9:30 am (Paris time). The other dates of the 2026 financial calendar remain unchanged. Press Contact Analyst Contact RUBIS - Communication departmentRUBIS - Clémence Mignot-Dupeyrot, Head of IRTel: +33 (0)1 44 17 95 95presse@rubis.frTel: +33 ( ...
Average 30-Year Fixed-Rate Mortgage Hits Another Low
Globenewswire· 2026-02-19 17:00
Primary Mortgage Market Survey® U.S. weekly average mortgage rates as of 02/19/2026 MCLEAN, Va., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.01%. “Mortgage rates dropped again this week, now down to their lowest level since September of 2022,” said Sam Khater, Freddie Mac’s Chief Economist. “This lower rate environment is not only improving affordability for ...
Marie Brizard Wine & Spirits: Q4 2025 and full-year 2025 revenues
Globenewswire· 2026-02-19 16:52
Core Insights - The company reported a decline in revenues for FY 2025, totaling €172.0 million, which represents an 8.6% decrease compared to 2024 [1] - Q4 2025 revenues were €44.6 million, down 6.9% year-over-year [1] Financial Performance - France's revenues fell by 12.9% to €19.2 million in Q4 2025, primarily due to complex trade negotiations with Off-Trade customers [2] - The overall revenue for the France Cluster in 2025 was €69.1 million, down 17.6% from 2024 [11] - The International Cluster recorded revenues of €102.9 million in 2025, a decline of 1.4% compared to the previous year [15] Market Dynamics - The global spirits market experienced a significant slowdown, impacting the company's performance [1] - The William Peel brand faced delisting by certain distributors, leading to a loss of market share [9][12] - The On-Trade market showed strong performance with a growth of 35.2% throughout 2025 [9] Regional Insights - In the United States, Q4 2025 revenues increased by 32.9%, driven by the Marie Brizard brand, although the annual performance showed a decline of 19.4% [21] - Spain's sales in Q4 2025 rose by 42.5%, largely due to a significant increase in Industrial Services activity [17] - Sales in Denmark fell by 25.7% in Q4 2025, contributing to an overall negative performance of -21.8% for the year [18] Strategic Initiatives - The company aims to focus on balanced commercial conditions with stakeholders and leverage its strategic assets for profitable growth [26][27] - An acquisition of a distribution company in Denmark at the end of 2025 is expected to enhance the company's brand portfolio and distribution capacity [28]
Marimekko Corporation: Repurchase of own shares on 19 February 2026
Globenewswire· 2026-02-19 16:45
Marimekko Corporation, Stock Exchange Release, 19 February 2026 at 18.45 p.m. EET Marimekko Corporation: Repurchase of own shares on 19 February 2026 Marimekko Corporation (LEI: 74370053IOY42B9YJ350) has acquired its own shares (ISIN FI0009007660) as follows: Trade date19 February 2026Bourse tradeBuyShareMEKKOVolume7,400Average price/share, EUR11.4135Total price, EUR84,459.90 On 12 February 2026, Marimekko announced that it will start acquiring the company’s own shares based on the authorization granted by ...
GTT : Full Year 2025 Results - Strong growth in revenues (+25%) and EBITDA (+40%) for the third consecutive year.
Globenewswire· 2026-02-19 16:45
Core Insights - GTT reported strong financial performance for FY 2025, with revenues increasing by 25% to €803 million and EBITDA rising by 40% to €542 million, marking the third consecutive year of growth [3][9][36] - The company announced a record dividend of €8.94 per share for 2025, up 19% from the previous year [3][43] - A significant increase in LNG carrier orders was noted, with 45 orders received during the financial year, including 37 for LNG carriers [8][11] Financial Performance - Consolidated revenues for 2025 were €803 million, a 25% increase from €641 million in 2024 [3][35] - EBITDA for 2025 reached €542 million, reflecting a 40% increase from €388 million in 2024, with an EBITDA margin of 67.5% [36][39] - Net income for 2025 was €413.6 million, an 18.9% increase from €347.8 million in 2024, with net earnings per share rising to €11.2 [39][40] Operational Highlights - GTT's order book as of December 31, 2025, included 288 units for its core business and 48 units for LNG as fuel [8][34] - The company received a record number of final investment decisions for new LNG trains, totaling 84 million tonnes per annum (Mtpa) in 2025 [8] - The acquisition of Danelec in July 2025 enhanced GTT's digital solutions, contributing €16.1 million to revenues in 2025 [19][22] Market Position and Strategy - GTT is positioned as a leader in the LNG value chain, benefiting from increased global demand for liquefied natural gas [5][6] - The company plans to maintain its dividend policy and expects consolidated revenues for 2026 to be between €740 million and €780 million, with EBITDA projected between €490 million and €530 million [52][45] - GTT's strategic ventures fund made two additional investments in 2025, expanding its portfolio to nine stakes [27][28] Innovation and Development - GTT filed 68 patents in 2025, maintaining a strong focus on innovation and R&D [25] - The company received several approvals from classification societies for its optimized containment systems, enhancing its competitive edge in the market [25][26] - GTT's digital solutions division saw revenues more than double to €36.1 million, driven by successful contracts and the integration of Danelec [22][21]
KLÉPIERRE: 2025 EARNINGS UP +5%, NAV UP +9% CONFIDENT ABOUT 2026
Globenewswire· 2026-02-19 16:42
Core Insights - Klépierre reported a 5% increase in earnings and a 9% rise in NAV for 2025, expressing confidence for 2026 [1][2][19] Financial Performance - Net current cash flow increased by 5% year-on-year to €2.72 per share, surpassing previous guidance [3][6] - EBITDA reached €1,119.3 million, up 5.5% year-on-year [3][6] - NAV per share rose by 9% to €35.9, driven by a 4.9% like-for-like portfolio value appreciation [7][10] - Total accounting return was 15% for 2025, with a cumulative return of 31.4% over the last two years [7][8] Operational Highlights - Net rental income grew by 5.1% year-on-year to €1,120.4 million, supported by a 4.5% like-for-like growth [5][24] - Footfall increased by 1.8% and like-for-like retailer sales rose by 3.4%, outperforming national retail sales indices [2][3] - Financial occupancy rate improved to 97.1%, with a rental uplift of 4.6% [3][4] Capital Allocation and Investments - Klépierre raised €1 billion in new financing at a competitive yield of 3.3% with an average maturity of 8.5 years [9][10] - The company acquired the leading mall in Bari for €160 million, expected to generate high-single digit cash returns [11][19] - Extensions at Odysseum and new projects at Le Gru and Romagna are projected to yield above 8% [12][19] Sustainability and Governance - Klépierre aims for net-zero on scopes 1 and 2 by 2030, with significant improvements in energy intensity and waste management [14][15] - The company was recognized for its sustainability efforts, ranking first in the European Listed Real Estate category by GRESB [16][17] - Governance changes include the planned appointment of Ludovic Jacquot to the Supervisory Board [20][21]
Coface closes another strong year with 2025 net income at €222.0m, solvency at 197% and an 84% distribution for a proposed dividend of €1.25 per share
Globenewswire· 2026-02-19 16:36
Coface closes another strong year with 2025 net income at €222.0m, solvency at 197% and an 84% distribution for a proposed dividend of €1.25 per share Paris, 19 February 2026 - 17.35 Turnover: €1,847m, up +1.3% at constant FX and perimeter Insurance revenue is up +0.6% at constant FX, while customer activity is up +2.6%Client retention remains at a high level (+92.9%), while pricing remains negative at -1.6%, in line with historical trendsNon-insurance activities (factoring, information services and debt co ...